Introduction: Carbapenem resistance in Klebsiella pneumoniae (Kp) has led to increased use of colistin-based therapy in the intensive care units (ICUs). Lately however, colistin resistance among K. pneumoniae has been widely reported. This study aims to investigate the prevalence, and the potential risk factors associated with colistin resistant K. pneumoniae (ColRKp) in the intensive care unit (ICU).
Materials and methods: All ICU patients, above 18 years of age, with a culture positive blood stream infection were included. A case-control-control design was used. Patients with colistin resistant K. pneumoniae (ColRKp) blood stream infections (BSI) were defined as cases. These were compared to two control populations, Control Group A had Kp infections moderately sensitive to colistin (ColMSKp); and control group B who had other bacterial infections. 50 ColRKp isolates were subjected to whole genome sequencing (WGS).
Results: Lungs as the source of infection (13.9 % vs 6.4 %, p ≤ 0.05) and longer hospital stay (26 days vs 22 days, p ≤ 0.05) were the significant risk factors which correlated with acquisition of colistin resistance in Klebsiella pneumoniae. An increased 28-day mortality was noticed in control groups who were given colistin based upon their in vitro sensitivity, (group A, 79 % and group B, 75.8 %) compared to cases (56.9 %). From among the ColRKp isolates subjected to WGS, 72 % (n = 36) carried NDM with OXA-48 like (OXA-181/232) carbapenemases. Mutations were found in pmrA, in pmrB, pmrC and pmrABC gene. None of the isolates had insertion in mgrB gene, all isolates were negative for mcr gene variants.
Conclusions: Both NDM and OXA-48 like carbapenemases were present in ColRKp. Patients receiving colistin therapy based on their in vitro sensitivity had increased risk for developing resistance to colistin and 28-day mortality.
Purpose: The aim of this study is to evaluate the effectiveness of VITEK®2 and CHROMagar™ Candida Plus agar in the identification of C. auris, using MALDI-TOF MS results as the reference standard. Additionally, to assess antifungal susceptibility, the study compares the results of two widely used commercial methods in routine laboratory practice: VITEK®2 and Sensititre™ YeastOne™ (SYO).
Methods: A total of 63 C. auris isolates were included in the study. VITEK®2 results were evaluated in comparison to SYO, and categorical agreement, major error (ME), and very major error (VME) rates were calculated. MIC50, MIC90 values and resistance rates determined by both methods were compared. The Eagle effect was also investigated.
Results: The VITEK®2 results (74 %) and the morphological characteristics of colonies grown on CHROMagar™ Candida Plus (100 %) were found to be consistent with MALDI-TOF MS identification. In the SYO method, the MIC values for amphotericin B, fluconazole, and voriconazole were found to be higher compared to those obtained by VITEK®2. No resistance was detected against micafungin and anidulafungin. Resistance observed in relation to caspofungin MIC values was identified as the Eagle effect. MIC50 and MIC90 values determined by VITEK®2 were lower than those obtained by SYO, except for amphotericin B, for which VITEK®2 showed a higher MIC90 value.
Conclusion: In our study, it was observed that CHROMagar™ Candida Plus can be used as a screening method for the identification of C. auris in hospitals without access to MALDI-TOF MS. Incompatibility was detected in antifungal susceptibility testing, and the rates of major error (ME) and very major error (VME) were found to be high. For caspofungin, the high dilution range in the SYO method was determined which also detected the Eagle effect.
Endometriotic cyst infection is rare and typically associated with invasive pelvic procedures or pelvic inflammatory disease. We present a case of a 34-year-old nulligravida female with no recent surgical or gynaecological interventions, who developed acute abdominal pain due to a ruptured endometriotic cyst infected with Salmonella enterica serovar Typhi. This case underscores the potential for hematogenous spread of infection and the importance of considering infected endometriomas in the differential diagnosis of acute abdomen.

